Divi's Lab.

{
  "main_header": {
    "sid": 509760,
    "name": "Divi's Lab.",
    "stock_name": "Divi's Lab.",
    "full_name": "Divis Laboratories Ltd",
    "name_url": "stocks-analysis/divi-s-lab",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "6,712.00",
    "chg": -2,
    "chgp": "-0.03%",
    "dir": -1,
    "prev_price": "6,714.00",
    "mcapval": "178,182.51 Cr",
    "mcap": "Large Cap",
    "scripcode": 532488,
    "symbol": "DIVISLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE361B01024",
    "curr_date": "May 12",
    "curr_time": "",
    "bse_nse_vol": "36.23 k",
    "exc_status": "Active",
    "traded_date": "May 12, 2026",
    "traded_date_str": "2026 05 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/divi-s-lab-509760-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Divis Laboratories Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-downgraded-to-sell-amid-mixed-financial-and-technical-signals-3986789",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_mojoScore_3986789.png",
        "date": "2026-05-12 08:17:09",
        "description": "Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 11 May 2026. This revision reflects a combination of deteriorating technical indicators, expensive valuation metrics, and subdued long-term financial growth despite strong recent earnings and market outperformance."
      },
      {
        "title": "Divis Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3986436",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_technicaldot_3986436.png",
        "date": "2026-05-12 08:03:37",
        "description": "Divis Laboratories Ltd has experienced a subtle but notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite this, the stock continues to demonstrate resilience with mixed signals from key technical indicators such as MACD, RSI, and moving averages, reflecting a complex market sentiment for this large-cap pharmaceutical player."
      },
      {
        "title": "Divis Laboratories Gains 1.37%: Technical Stabilisation and Financial Strength Drive Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-gains-137-technical-stabilisation-and-financial-strength-drive-week-3983608",
        "imagepath": "",
        "date": "2026-05-09 17:06:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Week opens at Rs.6,618.20</p>\n                    <p><strong>5 May:</strong> Mojo Grade upgraded to Hold by MarketsMOJO</p>\n                    <p><strong>6 May:</strong> Stock gains 0.80% amid strong Sensex rally</p>\n                    <p><strong>8 May:</strong> Week closes at Rs.6,708.90 (+1.37%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.6,618.20</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.6,708.90</div><div class=\"stat-change positive\">+1.37%</div></di..."
      },
      {
        "title": "Divis Laboratories Ltd Upgraded to Hold by MarketsMOJO on Technical and Financial Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-ltd-upgraded-to-hold-by-marketsmojo-on-technical-and-financial-improvements-3975166",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_mojoScore_3975166.png",
        "date": "2026-05-05 08:17:33",
        "description": "Divis Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical outlook alongside steady financial performance. The upgrade, effective from 4 May 2026, is driven by a combination of enhanced technical indicators, stable quality metrics, valuation considerations, and positive financial trends, positioning the stock as a cautious but promising pick within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Divis Laboratories Ltd Technical Momentum Shifts Signal Stabilisation Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-technical-momentum-shifts-signal-stabilisation-amid-mixed-indicators-3974767",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_technicaldot_3974767.png",
        "date": "2026-05-05 08:03:01",
        "description": "Divis Laboratories Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more neutral sideways trend. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, and moving averages, suggesting a stabilising outlook for the large-cap pharmaceutical player amid broader market fluctuations."
      },
      {
        "title": "Divis Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-ltd-is-rated-sell-3972039",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_mojoScore_3972039.png",
        "date": "2026-05-01 10:10:42",
        "description": "Divis Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 May 2026, providing investors with an up-to-date perspective on its performance and outlook."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-bullish-market-positioning-3961148",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/DivisLaboratori_oi_spurts_by_underlying_3961148.png",
        "date": "2026-04-24 15:00:30",
        "description": "Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 12.58% surge in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a marginal dip in the stock price, the underlying volume and futures data suggest a complex interplay of bullish and cautious sentiment among traders."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3961020",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/DivisLaboratori_oi_spurts_by_underlying_3961020.png",
        "date": "2026-04-24 14:00:19",
        "description": "Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.14% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a marginal price decline of 0.33% on 24 Apr 2026, the stock outperformed its sector by 1.49%, reflecting complex underlying dynamics in trading behaviour and sentiment."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3959458",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/DivisLaboratori_oi_spurts_by_underlying_3959458.png",
        "date": "2026-04-23 15:00:24",
        "description": "Divis Laboratories Ltd, a large-cap pharmaceutical heavyweight, has witnessed a notable 13.7% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock underperformed its sector on 23 Apr 2026, reflecting a complex interplay between bullish bets and cautious sentiment."
      }
    ],
    "total": 623,
    "sid": "509760",
    "stock_news_url": "https://www.marketsmojo.com/news/divis-laboratories-509760"
  },
  "announcements": [
    {
      "details": "Divi's Laboratories Limited has informed the Exchange regarding Disclosure of Related Party Transaction under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Divi's Laboratories Limited - Other General Purpose",
      "datetime": "03-Dec-2019"
    },
    {
      "details": "Divi's Laboratories Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Divi's Laboratories Limited - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "18-Nov-2019"
    },
    {
      "details": "Divi's Laboratories Limited has informed the Exchange regarding 'US-FDA Inspection of Unit -I at village Lingojigudem, Bhuvanagiri Yadadri District, Telangana'.",
      "source": "NSE",
      "caption": "Divi's Laboratories Limited - Updates",
      "datetime": "15-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has declared <strong>1500%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 03 Aug 07",
          "dt": "2007-08-03",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 23 Sep 15",
          "dt": "2015-09-23",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Divis Laboratories Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-05-12 08:17:09

Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 11 May 2026. This revision reflects a combination of deteriorating technical indicators, expensive valuation metrics, and subdued long-term financial growth despite strong recent earnings and market outperformance.

Read full news article

Divis Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-12 08:03:37

Divis Laboratories Ltd has experienced a subtle but notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite this, the stock continues to demonstrate resilience with mixed signals from key technical indicators such as MACD, RSI, and moving averages, reflecting a complex market sentiment for this large-cap pharmaceutical player.

Read full news article

Divis Laboratories Gains 1.37%: Technical Stabilisation and Financial Strength Drive Week

2026-05-09 17:06:16

Key Events This Week

4 May: Week opens at Rs.6,618.20

5 May: Mojo Grade upgraded to Hold by MarketsMOJO

6 May: Stock gains 0.80% amid strong Sensex rally

8 May: Week closes at Rs.6,708.90 (+1.37%)

Week Open

Rs.6,618.20

Week Close

Rs.6,708.90

+1.37%

Read full news article

Divis Laboratories Ltd Upgraded to Hold by MarketsMOJO on Technical and Financial Improvements

2026-05-05 08:17:33

Divis Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical outlook alongside steady financial performance. The upgrade, effective from 4 May 2026, is driven by a combination of enhanced technical indicators, stable quality metrics, valuation considerations, and positive financial trends, positioning the stock as a cautious but promising pick within the Pharmaceuticals & Biotechnology sector.

Read full news article

Divis Laboratories Ltd Technical Momentum Shifts Signal Stabilisation Amid Mixed Indicators

2026-05-05 08:03:01

Divis Laboratories Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more neutral sideways trend. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, and moving averages, suggesting a stabilising outlook for the large-cap pharmaceutical player amid broader market fluctuations.

Read full news article

Divis Laboratories Ltd is Rated Sell

2026-05-01 10:10:42

Divis Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 May 2026, providing investors with an up-to-date perspective on its performance and outlook.

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning

2026-04-24 15:00:30

Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 12.58% surge in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a marginal dip in the stock price, the underlying volume and futures data suggest a complex interplay of bullish and cautious sentiment among traders.

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-04-24 14:00:19

Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.14% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a marginal price decline of 0.33% on 24 Apr 2026, the stock outperformed its sector by 1.49%, reflecting complex underlying dynamics in trading behaviour and sentiment.

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-04-23 15:00:24

Divis Laboratories Ltd, a large-cap pharmaceutical heavyweight, has witnessed a notable 13.7% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock underperformed its sector on 23 Apr 2026, reflecting a complex interplay between bullish bets and cautious sentiment.

Read full news article

View All News